Article Information
- Received March 31, 2021
- Revision received May 2, 2021
- Accepted August 25, 2021
- Published online September 3, 2021.
Author Information
- Kristyn N. Borrelli1,2,3,4,*,
- Emily J. Yao1,*,
- William W. Yen5,
- Rhushikesh A. Phadke5,6,
- Qiu T. Ruan1,3,4,
- Melanie M. Chen1,
- Julia C. Kelliher1,
- Carly R. Langan1,
- Julia L. Scotellaro1,7,
- Richard K. Babbs1,
- Jacob C. Beierle1,3,4,
- Ryan W. Logan8,9,
- William Evan Johnson10,
- Elisha M. Wachman11,
- Alberto Cruz-Martín5 and
- Camron D. Bryant1
- 1Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118
- 2Graduate Program for Neuroscience, Boston University, Boston, Massachusetts 02118
- 3Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118
- 4NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118
- 5Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215
- 6Molecular Biology, Cell Biology, and Biochemistry (MCBB), Boston University, Boston, Massachusetts 02215
- 7Undergraduate Research Opportunity Program, Boston University, Boston, Massachusetts 02118
- 8Laboratory of Sleep, Rhythms, and Addiction, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118
- 9Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, Maine 04609
- 10Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118
- 11Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts 02118
- Correspondence should be addressed to Camron D. Bryant at camron{at}bu.edu.
Author contributions
Author contributions: A.C.-M. and C.D.B. designed research; K.N.B., E.J.Y., M.M.C., J.C.K., C.R.L., J.L.S., R.K.B., J.C.B., E.M.W., A.C.-M., and C.D.B. performed research; K.N.B., E.J.Y., W.W.Y., R.A.P., Q.T.R., M.M.C., J.C.K., J.L.S., R.K.B., J.C.B., R.W.L., W.E.J., E.M.W., A.C.-M., and C.D.B. analyzed data; K.N.B., E.J.Y., W.W.Y., R.W.L., E.M.W., A.C.-M., and C.D.B. wrote the paper.
↵* K.N.B. and E.J.Y. contributed equally to this work.
Disclosures
The authors declare no competing financial interests.
This research was supported by the Spivack Center for Clinical and Translational Neuroscience; National Institute on Drug Abuse Grants U01-DA-050243 and R01-DA-039168 (C.D.B.); National Heart, Lung, and Blood Institute Grant R01-150432 (R.W.L); Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01-HD-096798 (E.W.); National Alliance for Research on Schizophrenia and Depression Young Investigator Grant 27202 (A.C-M.); and Boston University’s Undergraduate Research Opportunities Program (J.L.S.)
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
R01DA039168; U01DA050243HHS | NIH | NICHD | National Center for Medical Rehabilitation Research (NCMRR)
R01HD096798Brain and Behavior Research Foundation (Brain & Behavior Research Foundation)
27202
Other Version
- You are viewing the most recent version of this article.
- previous version (September 03, 2021).
Online Impact